301015 百洋医药
已收盘 10-29 15:00:00
资讯
新帖
简况
百洋医药三季报营收、利润双降：批发收缩致营收承压，非经营性损益放大利润降幅
蓝鲸财经 · 10:34
百洋医药三季报营收、利润双降：批发收缩致营收承压，非经营性损益放大利润降幅
图解百洋医药三季报：第三季度单季净利润同比下降95.24%
证券之星 · 01:43
图解百洋医药三季报：第三季度单季净利润同比下降95.24%
百洋医药涨10.62%，华鑫证券一个月前给出“买入”评级
证券之星 · 10-26
百洋医药涨10.62%，华鑫证券一个月前给出“买入”评级
百洋医药（301015）10月23日主力资金净卖出590.49万元
证券之星 · 10-26
百洋医药（301015）10月23日主力资金净卖出590.49万元
从“医药”到“制药”：百洋（301015）更名背后的战略进阶之路
同壁财经 · 10-25
从“医药”到“制药”：百洋（301015）更名背后的战略进阶之路
百洋医药涨6.30%，华鑫证券一个月前给出“买入”评级
证券之星 · 10-23
百洋医药涨6.30%，华鑫证券一个月前给出“买入”评级
股市必读：百洋医药新发布《第四届董事会第十二次会议决议公告》
证券之星 · 10-22
股市必读：百洋医药新发布《第四届董事会第十二次会议决议公告》
百洋医药（301015）披露涉及重大诉讼事项公告，10月21日股价上涨0.36%
证券之星 · 10-21
百洋医药（301015）披露涉及重大诉讼事项公告，10月21日股价上涨0.36%
股市必读：百洋医药新发布《第四届董事会第十二次会议决议公告》
证券之星 · 10-21
股市必读：百洋医药新发布《第四届董事会第十二次会议决议公告》
百洋医药（301015）披露拟变更公司名称及修订公司章程议案，10月20日股价上涨4.64%
证券之星 · 10-20
百洋医药（301015）披露拟变更公司名称及修订公司章程议案，10月20日股价上涨4.64%
百洋医药(301015.SZ)：证券简称拟变更为“百洋制药”
智通财经网 · 10-20
百洋医药(301015.SZ)：证券简称拟变更为“百洋制药”
百洋医药（301015）10月16日主力资金净卖出3278.65万元
证券之星 · 10-19
百洋医药（301015）10月16日主力资金净卖出3278.65万元
百洋医药（301015）10月15日主力资金净卖出932.43万元
证券之星 · 10-16
百洋医药（301015）10月15日主力资金净卖出932.43万元
股市必读：百洋医药新发布《关于控股股东部分股份解除质押的公告》
证券之星 · 10-16
股市必读：百洋医药新发布《关于控股股东部分股份解除质押的公告》
股市必读：百洋医药新发布《北京市天元律师事务所关于青岛百洋医药股份有限公司2026年第三次临时股东会的法律意见》
证券之星 · 10-12
股市必读：百洋医药新发布《北京市天元律师事务所关于青岛百洋医药股份有限公司2026年第三次临时股东会的法律意见》
百洋医药（301015）9月30日主力资金净买入472.20万元
证券之星 · 10-08
百洋医药（301015）9月30日主力资金净买入472.20万元
股市必读：百洋医药（301015）9月30日董秘有最新回复
证券之星 · 10-08
股市必读：百洋医药（301015）9月30日董秘有最新回复
股市必读：百洋医药（301015）9月24日董秘有最新回复
证券之星 · 09-28
股市必读：百洋医药（301015）9月24日董秘有最新回复
股市必读：百洋医药新发布《第四届董事会第十一次会议决议公告》
证券之星 · 09-24
股市必读：百洋医药新发布《第四届董事会第十一次会议决议公告》
百洋医药(301015.SZ)拟1.56亿元参投门头沟百洋基金
智通财经 · 09-22
百洋医药(301015.SZ)拟1.56亿元参投门头沟百洋基金
加载更多
公司概况
公司名称：
青岛百洋医药股份有限公司
所属行业：
批发业
上市日期：
2021-06-30
主营业务：
青岛百洋医药股份有限公司的主营业务是医学创新成果的产品开发、生产制造和商业化运营。公司的主要产品是品牌运营业务、批发配送业务。
发行价格：
7.64
{"stockData":{"symbol":"301015","market":"SZ","secType":"STK","nameCN":"百洋医药","latestPrice":22.71,"timestamp":1793257395000,"preClose":23.98,"halted":0,"volume":12264495,"delay":0,"changeRate":-0.053,"floatShares":526000000,"shares":526000000,"eps":0.4526,"marketStatus":"已收盘","change":-1.27,"latestTime":"10-29 15:00:00","open":22.83,"high":24.83,"low":22.69,"amount":286000000,"amplitude":0.0892,"askPrice":22.72,"askSize":7,"bidPrice":22.71,"bidSize":158,"shortable":0,"etf":0,"ttmEps":0.4526,"tradingStatus":0,"nextMarketStatus":{"tag":"开盘","tradingStatus":2,"beginTime":1793323800000},"marketStatusCode":5,"adr":0,"adjPreClose":23.98,"symbolType":"stock","openAndCloseTimeList":[[1793237400000,1793244600000],[1793250000000,1793257200000]],"highLimit":26.38,"lowLimit":21.58,"ibTradeSell":false,"ibTradeBuySell":false,"totalEquity":525624077,"isCdr":false,"pbRate":5.49,"roa":"--","peRate":50.176757,"roe":"10.19%","epsLYR":0.9,"committee":0.499222,"marketValue":11937000000,"turnoverRate":0.0233,"status":1,"floatMarketCap":11935000000},"requestUrl":"/m/hq/s/301015","defaultTab":"news","newsList":[{"id":"2679421814","title":"百洋医药三季报营收、利润双降：批发收缩致营收承压，非经营性损益放大利润降幅","url":"https://stock-news.laohu8.com/highlight/detail?id=2679421814","media":"蓝鲸财经","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2679421814?lang=zh_cn&edition=full","pubTime":"2026-10-29 10:34","pubTimestamp":1793241295,"startTime":"0","endTime":"0","summary":"前三季度，公司实现营业收入52.18亿元，同比下降7.27%；归母净利润2.40亿元，同比下降49.71%；扣非净利润2.56亿元，同比下降37.58%。从主营业务构成来看，百洋医药收入来源主要包括核心品牌运营、批发配送和零售业务。整体而言，百洋医药试图用短期的营收收缩和利润波动，换取业务结构的优化和创新能力的积累，但真正验证还需时间。","market":"sh","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["earning"],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.lanjinger.com/d/1793241087987605186","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"lanjinger_stock","symbols":["301015"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2679418882","title":"图解百洋医药三季报：第三季度单季净利润同比下降95.24%","url":"https://stock-news.laohu8.com/highlight/detail?id=2679418882","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2679418882?lang=zh_cn&edition=full","pubTime":"2026-10-29 01:43","pubTimestamp":1793209419,"startTime":"0","endTime":"0","summary":"证券之星消息，百洋医药2026年三季报显示，前三季度公司主营收入52.18亿元，同比下降7.27%；归母净利润2.4亿元，同比下降49.71%；扣非净利润2.56亿元，同比下降37.58%；其中2026年第三季度，公司单季度主营收入16.59亿元，同比下降11.58%；单季度归母净利润1492.15万元，同比下降95.24%；单季度扣非净利润3478.64万元，同比下降85.03%；负债率66.22%，投资收益-3535.01万元，财务费用8819.9万元，毛利率39.06%。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["earning"],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026102900003344.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["301015"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2678163417","title":"百洋医药涨10.62%，华鑫证券一个月前给出“买入”评级","url":"https://stock-news.laohu8.com/highlight/detail?id=2678163417","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2678163417?lang=zh_cn&edition=full","pubTime":"2026-10-26 16:44","pubTimestamp":1793004264,"startTime":"0","endTime":"0","summary":"今日百洋医药涨10.62%，收盘报25.0元。2026年9月10日，华鑫证券研究员胡博新,吴景欢发布了对百洋医药的研报《公司事件点评报告：业务结构优化成效显著，布局创新药械打造第二增长曲线》，该研报对百洋医药给出“买入”评级。首次覆盖，给予“买入”投资评级。证券之星数据中心计算显示，对该股盈利预测较准的分析师团队为东方证券的袁润璞。百洋医药个股概况：以上内容为证券之星据公开信息整理，仅供参考不构成投资建议。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["rate"],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026102600022132.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["301015","161027"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2678379051","title":"百洋医药（301015）10月23日主力资金净卖出590.49万元","url":"https://stock-news.laohu8.com/highlight/detail?id=2678379051","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2678379051?lang=zh_cn&edition=full","pubTime":"2026-10-26 09:08","pubTimestamp":1792976910,"startTime":"0","endTime":"0","summary":"证券之星消息，截至2026年10月23日收盘，百洋医药报收于22.6元，上涨6.3%，换手率1.91%，成交量10.05万手，成交额2.17亿元。近5日资金流向一览见下表：百洋医药融资融券信息显示，融资方面，当日融资买入1255.81万元，融资偿还2126.22万元，融资净偿还870.41万元。百洋医药主营业务：核心业务聚焦医学创新成果的产品开发、生产制造和商业化运营。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026102600003172.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0250","301015"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2678138256","title":"从“医药”到“制药”：百洋（301015）更名背后的战略进阶之路","url":"https://stock-news.laohu8.com/highlight/detail?id=2678138256","media":"同壁财经","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2678138256?lang=zh_cn&edition=full","pubTime":"2026-10-25 18:01","pubTimestamp":1792922460,"startTime":"0","endTime":"0","summary":"10月21日，百洋医药发布重磅公告：公司名称拟变更为“百洋制药集团股份有限公司”，证券简称变更为“百洋制药”。从“医药”到“制药”，仅一字之差，却向资本市场释放了极其强烈的价值重估信号：百洋除了有“商业化平台”标签，另外正式迈入拥有“自有品牌+自主全球知识产权”的生态型大型制药企业之路。百洋的第三个十年，大幕已启。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://finance.sina.com.cn/stock/relnews/cn/2026-10-25/doc-iniwmxsr6275183.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"sina","symbols":["BK1191","09939","BK0250","BK1574","159938","01477","BK1161","BK1515","301015"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2677944046","title":"百洋医药涨6.30%，华鑫证券一个月前给出“买入”评级","url":"https://stock-news.laohu8.com/highlight/detail?id=2677944046","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2677944046?lang=zh_cn&edition=full","pubTime":"2026-10-23 16:51","pubTimestamp":1792745508,"startTime":"0","endTime":"0","summary":"今日百洋医药涨6.30%，收盘报22.6元。2026年9月10日，华鑫证券研究员胡博新,吴景欢发布了对百洋医药的研报《公司事件点评报告：业务结构优化成效显著，布局创新药械打造第二增长曲线》，该研报对百洋医药给出“买入”评级。首次覆盖，给予“买入”投资评级。证券之星数据中心计算显示，对该股盈利预测较准的分析师团队为东方证券的袁润璞。百洋医药个股概况：以上内容为证券之星据公开信息整理，仅供参考不构成投资建议。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["rate"],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026102300030678.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["161027","301015"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2677012416","title":"股市必读：百洋医药新发布《第四届董事会第十二次会议决议公告》","url":"https://stock-news.laohu8.com/highlight/detail?id=2677012416","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2677012416?lang=zh_cn&edition=full","pubTime":"2026-10-22 03:40","pubTimestamp":1792611620,"startTime":"0","endTime":"0","summary":"公司公告汇总第四届董事会第十二次会议决议公告青岛百洋医药股份有限公司于2026年10月20日召开第四届董事会第十二次会议，审议通过《关于拟变更公司名称、证券简称、经营范围及修订〈公司章程〉的议案》和《关于召开2026年第四次临时股东会的议案》。本次变更已获董事会审议通过，尚需提交股东会审议及市场监督管理部门核准。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026102200003365.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["301015","BK0250"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2677260838","title":"百洋医药（301015）披露涉及重大诉讼事项公告，10月21日股价上涨0.36%","url":"https://stock-news.laohu8.com/highlight/detail?id=2677260838","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2677260838?lang=zh_cn&edition=full","pubTime":"2026-10-21 22:49","pubTimestamp":1792594150,"startTime":"0","endTime":"0","summary":"截至2026年10月21日收盘，百洋医药报收于22.42元，较前一交易日上涨0.36%，最新总市值为117.84亿元。该股当日开盘22.3元，最高22.7元，最低22.07元，成交额达1.1亿元，换手率为0.94%。公司于2026年10月21日披露《中证鹏元关于关注青岛百洋医药股份有限公司涉及重大诉讼事项的公告》。公告显示，公司全资子公司百洋智合起诉扬州一洋制药有限公司服务合同纠纷案，诉讼请求金额合计13.83亿元，包括终止协议违约金12.16亿元。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026102100041850.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["301015","BK0250"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2677615559","title":"股市必读：百洋医药新发布《第四届董事会第十二次会议决议公告》","url":"https://stock-news.laohu8.com/highlight/detail?id=2677615559","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2677615559?lang=zh_cn&edition=full","pubTime":"2026-10-21 03:04","pubTimestamp":1792523053,"startTime":"0","endTime":"0","summary":"公司公告汇总第四届董事会第十二次会议决议公告青岛百洋医药股份有限公司于2026年10月20日召开第四届董事会第十二次会议，审议通过《关于拟变更公司名称、证券简称、经营范围及修订〈公司章程〉的议案》和《关于召开2026年第四次临时股东会的议案》。本次变更已获董事会审议通过，尚需提交股东会审议及市场监督管理部门核准。本次担保在公司2025年年度股东会审议通过的担保额度范围内，无需另行审议。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026102100001984.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["301015","BK0250"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2676944756","title":"百洋医药（301015）披露拟变更公司名称及修订公司章程议案，10月20日股价上涨4.64%","url":"https://stock-news.laohu8.com/highlight/detail?id=2676944756","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2676944756?lang=zh_cn&edition=full","pubTime":"2026-10-20 22:36","pubTimestamp":1792506974,"startTime":"0","endTime":"0","summary":"截至2026年10月20日收盘，百洋医药报收于22.34元，较前一交易日上涨4.64%，最新总市值为117.42亿元。近日，百洋医药发布《关于召开2026年第四次临时股东会的通知》。会议将审议《关于拟变更公司名称、证券简称、经营范围及修订〈公司章程〉的议案》，该议案为特别决议事项，需经出席会议股东所持表决权的三分之二以上通过。登记时间截至2026年10月30日17:00，可通过现场、信函或邮件方式登记。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026102000037139.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0250","301015"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2676661867","title":"百洋医药(301015.SZ)：证券简称拟变更为“百洋制药”","url":"https://stock-news.laohu8.com/highlight/detail?id=2676661867","media":"智通财经网","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2676661867?lang=zh_cn&edition=full","pubTime":"2026-10-20 17:37","pubTimestamp":1792489070,"startTime":"0","endTime":"0","summary":"百洋医药(301015.SZ)发布公告，为精准体现业务发展方向和未来战略规划，全面反映公司布局与业务实质，公司拟变更公司名称及证券简称，同时，基于公司经营发展需要，拟对公司经营范围进行变更，并根据上述变更情况对《公司章程》相关条款进行修订。公司名称拟由“青岛百洋医药股份有限公司”变更为“百洋制药集团股份有限公司”，证券简称拟由“百洋医药”变更为“百洋制药”，英文名称及英文简称作相应变更，证券代码保持不变。","market":"sh","thumbnail":"https://img.zhitongcaijing.com/astockgonggao/agugonggao9.png?x-oss-process=image/format,jpg/quality,Q_80/resize,w_250","type":0,"news_type":0,"thumbnails":["https://img.zhitongcaijing.com/astockgonggao/agugonggao9.png?x-oss-process=image/format,jpg/quality,Q_80/resize,w_250"],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1509488.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"highlight_zhitongcaijin","symbols":["BK1574","BK1191","301015","BK0250","161027","01477"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2676579017","title":"百洋医药（301015）10月16日主力资金净卖出3278.65万元","url":"https://stock-news.laohu8.com/highlight/detail?id=2676579017","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2676579017?lang=zh_cn&edition=full","pubTime":"2026-10-19 09:12","pubTimestamp":1792372354,"startTime":"0","endTime":"0","summary":"证券之星消息，截至2026年10月16日收盘，百洋医药报收于22.6元，下跌5.48%，换手率2.99%，成交量15.73万手，成交额3.73亿元。近5日资金流向一览见下表：百洋医药融资融券信息显示，融资方面，当日融资买入3023.36万元，融资偿还4295.7万元，融资净偿还1272.34万元。百洋医药主营业务：核心业务聚焦医学创新成果的产品开发、生产制造和商业化运营。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026101900002452.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["301015","BK0250"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2675855170","title":"百洋医药（301015）10月15日主力资金净卖出932.43万元","url":"https://stock-news.laohu8.com/highlight/detail?id=2675855170","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2675855170?lang=zh_cn&edition=full","pubTime":"2026-10-16 09:11","pubTimestamp":1792113067,"startTime":"0","endTime":"0","summary":"证券之星消息，截至2026年10月15日收盘，百洋医药报收于23.91元，下跌8.67%，换手率3.92%，成交量20.61万手，成交额5.27亿元。近5日资金流向一览见下表：百洋医药融资融券信息显示，融资方面，当日融资买入5652.54万元，融资偿还5594.81万元，融资净买入57.74万元，连续3日净买入累计699.48万元。百洋医药主营业务：核心业务聚焦医学创新成果的产品开发、生产制造和商业化运营。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026101600008828.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["301015","BK0250"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2675534385","title":"股市必读：百洋医药新发布《关于控股股东部分股份解除质押的公告》","url":"https://stock-news.laohu8.com/highlight/detail?id=2675534385","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2675534385?lang=zh_cn&edition=full","pubTime":"2026-10-16 01:48","pubTimestamp":1792086495,"startTime":"0","endTime":"0","summary":"截至2026年10月15日收盘，百洋医药报收于23.91元，下跌8.67%，换手率3.92%，成交量20.61万手，成交额5.27亿元。当日关注点交易信息汇总：10月15日主力资金净流出932.43万元，占总成交额1.77%。公司公告汇总：控股股东百洋医药集团有限公司解除质押6,771,768股，占公司总股本1.29%。截至公告日，控股股东及其一致行动人累计质押股份185,220,613股，占其所持股份比例47.38%，占公司总股本比例35.24%。所质押股份不存在平仓风险，亦无股份被冻结或拍卖情况。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026101600002194.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["301015","BK0250"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2674846834","title":"股市必读：百洋医药新发布《北京市天元律师事务所关于青岛百洋医药股份有限公司2026年第三次临时股东会的法律意见》","url":"https://stock-news.laohu8.com/highlight/detail?id=2674846834","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2674846834?lang=zh_cn&edition=full","pubTime":"2026-10-12 03:05","pubTimestamp":1791745514,"startTime":"0","endTime":"0","summary":"公司公告汇总北京市天元律师事务所关于青岛百洋医药股份有限公司2026年第三次临时股东会的法律意见青岛百洋医药股份有限公司于2026年10月9日召开2026年第三次临时股东会，会议采取现场与网络投票相结合方式。北京市天元律师事务所出具法律意见，认为本次股东会召集、召开程序合法，表决结果有效。关于2026年第三季度可转换公司债券转股情况的公告青岛百洋医药股份有限公司发布关于2026年第三季度可转换公司债券转股情况的公告。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026101200000992.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0250","301015"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2673049092","title":"百洋医药（301015）9月30日主力资金净买入472.20万元","url":"https://stock-news.laohu8.com/highlight/detail?id=2673049092","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2673049092?lang=zh_cn&edition=full","pubTime":"2026-10-08 09:08","pubTimestamp":1791421720,"startTime":"0","endTime":"0","summary":"证券之星消息，截至2026年9月30日收盘，百洋医药报收于25.68元，上涨2.56%，换手率1.24%，成交量6.5万手，成交额1.66亿元。近5日资金流向一览见下表：百洋医药融资融券信息显示，融资方面，当日融资买入2038.76万元，融资偿还2088.07万元，融资净偿还49.31万元。百洋医药主营业务：核心业务聚焦医学创新成果的产品开发、生产制造和商业化运营。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026100800003028.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0250","301015"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2673181012","title":"股市必读：百洋医药（301015）9月30日董秘有最新回复","url":"https://stock-news.laohu8.com/highlight/detail?id=2673181012","media":"证券之星","labels":["executive"],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2673181012?lang=zh_cn&edition=full","pubTime":"2026-10-08 02:11","pubTimestamp":1791396670,"startTime":"0","endTime":"0","summary":"截至2026年9月30日收盘，百洋医药报收于25.68元，上涨2.56%，换手率1.24%，成交量6.5万手，成交额1.66亿元。董秘最新回复投资者： 董秘您好，吉伦泰今年4月已经获批上市，至今接近半年尚未完成首省挂网。想请教：1、目前首省挂网申报是否已经全部提交完毕？当日关注点交易信息汇总：9月30日主力资金净流入472.2万元，游资资金净流入939.21万元，散户资金净流出1411.41万元。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026100800001150.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"executive","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0250","301015"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2670409873","title":"股市必读：百洋医药（301015）9月24日董秘有最新回复","url":"https://stock-news.laohu8.com/highlight/detail?id=2670409873","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2670409873?lang=zh_cn&edition=full","pubTime":"2026-09-28 01:10","pubTimestamp":1790529023,"startTime":"0","endTime":"0","summary":"截至2026年9月24日收盘，百洋医药报收于25.23元，下跌3.41%，换手率1.09%，成交量5.73万手，成交额1.47亿元。6月4日回复一季度现金流下降是因为新品备货，二季度还是因为新品吗？具体经营事项公司将严格按照相关规定履行披露义务，请以公司公告为准，感谢您的关注与支持。当日关注点交易信息汇总：9月24日主力资金净流出2232.91万元，占总成交额15.19%。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026092800000744.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["301015","BK0250"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2669433395","title":"股市必读：百洋医药新发布《第四届董事会第十一次会议决议公告》","url":"https://stock-news.laohu8.com/highlight/detail?id=2669433395","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2669433395?lang=zh_cn&edition=full","pubTime":"2026-09-24 02:01","pubTimestamp":1790186477,"startTime":"0","endTime":"0","summary":"公司公告汇总：拟续聘立信会计师事务所为2026年度审计机构，审计费用200万元，与上年持平，尚需股东大会审议。关于召开2026年第三次临时股东会的通知青岛百洋医药股份有限公司将于2026年10月9日召开2026年第三次临时股东会，现场会议时间为当日14:00，网络投票时间为9:15至15:00。本次交易构成关联交易，已获董事会审议通过，尚需提交股东大会审议。本次投资完成后，公司间接合计持有标的公司20.86%股权。本次投资不会导致公司合并报表范围变更。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026092400002264.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0250","301015"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2669975148","title":"百洋医药(301015.SZ)拟1.56亿元参投门头沟百洋基金","url":"https://stock-news.laohu8.com/highlight/detail?id=2669975148","media":"智通财经","labels":["corporation"],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2669975148?lang=zh_cn&edition=full","pubTime":"2026-09-22 17:40","pubTimestamp":1790070000,"startTime":"0","endTime":"0","summary":"智通财经APP讯，百洋医药 发布公告，公司拟与北京百洋众信康健投资管理有限公司、北京市门头沟区京西产业引导基金、共青城万衡创业投资合伙企业共同出资设立北京市门头沟区百洋三期医药产业投资基金合伙企业。门头沟百洋基金的认缴出资额为4亿元，公司拟作为有限合伙人以自有资金认缴出资1.56亿元，占出资总额的39%。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1499344.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"corporation","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["301015","BK0250"],"isVideo":false,"video":null,"gpt_icon":0}],"profile":{"ret":0,"serverTime":1793266436107,"stockEarnings":[{"period":"1week","weight":0.0696},{"period":"1month","weight":-0.0389},{"period":"3month","weight":0.071},{"period":"6month","weight":-0.0017},{"period":"1year","weight":-0.0531},{"period":"ytd","weight":0.0427}],"compareEarnings":[{"period":"1week","weight":-0.0085},{"period":"1month","weight":-0.0372},{"period":"3month","weight":-0.0324},{"period":"6month","weight":-0.1047},{"period":"1year","weight":-0.0769},{"period":"ytd","weight":-0.0724}],"compareStock":{"symbol":"000001.SH","name":"上证指数"},"companyName":"青岛百洋医药股份有限公司","boardCode":"AI0051","boardName":"批发业","stockholders":"15300人(较上一季度增加1.55%)","perCapita":"34350股","listingDate":"2021-06-30","address":"山东省青岛市市北区桐柏路88号1号楼","registeredCapital":"52562万元","survey":" 青岛百洋医药股份有限公司的主营业务是医学创新成果的产品开发、生产制造和商业化运营。公司的主要产品是品牌运营业务、批发配送业务。","listedPrice":7.64},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":false,"isLaohu8Offline":false,"tenantId":"TBCN","deviceId":"web-server-community-laohu8-v3","version":"4.52.0","shortVersion":"4.52.0","platform":"web","vendor":"web","appName":"laohu8","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"pagemeta":{"title":"百洋医药(301015)_个股概要_股票价格_最新资讯_行情走势_历史数据","description":"美港股上老虎。老虎社区提供百洋医药(301015)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","keywords":"百洋医药,301015,百洋医药股票,百洋医药股票老虎,百洋医药股票老虎国际,百洋医药行情,百洋医药股票行情,百洋医药股价,百洋医药股市,百洋医药股票价格,百洋医药股票交易,百洋医药股票购买,百洋医药股票实时行情,购买美股,购买港股,港股开户,美股开户,美股交易,港股交易,开通美港股账户,老虎国际行情","social":{"og_title":"百洋医药(301015)_个股概要_股票价格_最新资讯_行情走势_历史数据","og_description":"美港股上老虎。老虎社区提供百洋医药(301015)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","og_image":"https://static.tigerbbs.com/a0b84b8debbbce3b4440f7fdd5eed2e7"}}}